Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2006 Jul;10(3):99-104.

Hemolytic uremic syndrome after renal transplantation

G V Vergoulas  1
Affiliations

Hemolytic uremic syndrome after renal transplantation

G V Vergoulas. Hippokratia. 2006 Jul.

Abstract

Hemolytic Uremic Syndrome after kidney transplantation affects an increasing number of patients. It is characterized as recurrent and de novo. Older age at onset of HUS, shorter mean interval between HUS and transplantation or ESRD, living related donor and treatment with CNI have been associated with an increased risk of recurrence. Patients who lost the first transplant because of HUS recurrence should not receive a second transplant. The outcome of recurring HUS after transplantation is worse in familial forms leading invariably to graft loss and for this reason doctors should discourage the use of living related donors in this setting. De novo HUS is not a rare complication after kidney transplantation and may be associated with infection, CNI or mTOR inhibitor toxicity, antibody use (OKT3), or acute vascular rejection. The clinical picture is obscure and treatment rests on removal of inciting factor with or without plasma exchange/FFP infusion.

Keywords: hemolytic uremic syndrome; kidney transplantation.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

References

    1. Schwimmer J, Nadasdy TA, Spitalnik PF, Kaplan KL, Xand MS. De novo thrombotic microangiopathy in renal transplant recipients: a comparison of hemolytic uremic syndrome with localized renal thrombotic microangiopathy. Am J Kidney Dis. 2003;41:471–479. - PubMed
    1. Remuzzi G. HUS and TTP: Variable expression of a single entity. Kidney Int. 1987;32:292–308. - PubMed
    1. Kaplan BS, Kaplan B. Hemolytic uremic syndrome in families. In: Kaplan BS, Trompeter RS, Moake JL, editors. Hemolytic Uremic Syndrome and Thrombotic Thrombocytopenic Purpura. NY: Marcel Dekker; 1992. pp. 23–225.
    1. Meroni M, Volpi A, Battini G, et al. Reccurent hemolytic syndrome: Case report. Nephron. 1986;44:263–264. - PubMed
    1. Pettit RM. Thrombotic thrombocytopenic purpura; a thirty year review. Semin Thromb Hemost. 1980;6:350–355. - PubMed

LinkOut - more resources